Close Menu

BMS

The American Society of Clinical Oncology held its annual meeting June 1-5 in Chicago. The following are abstracts presented at the meeting focused on pharmacogenomically guided treatment strategies.

Eli Lilly said last week that it received a complete response letter from the US Food and Drug Administration declining its application to market Erbitux as a first-line treatment for non-small cell lung cancer.

By Adam Bonislawski
Researchers at Australia's University of Newcastle have published one of the first analyses of data from the Alzheimer's Disease Neuroimaging Initiative's plasma proteome project.

This article was originally posted March 29.
The annual meeting of the American College of Cardiology held last week in Chicago featured a number of pharmacogenomically guided studies related to treatments for cardiovascular disease.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Bristol-Myers Squibb and Meso Scale Discovery today announced a deal to develop assays for use in Alzheimer's disease research.

By Monica Heger

Despite being the third best-selling drug in 2010, as many as one-third of cardiology patients do not respond to Bristol-Myers Squibb's blood-thinning drug Plavix (clopidogrel).

By Adam Bonislawski
Biotech firm KineMed said this week that it has signed a research collaboration agreement with Pfizer to investigate therapies for metabolic diseases, particularly type 2 diabetes.

Pages

NPR reports that many USDA researchers working at the two agencies that are relocating to the Kansas City area are declining to go.

Genetic genealogy has helped exonerate a man who has been jailed for 20 years, Agence France Presse reports.

A new report says genetically modified food might be necessary to be able to feed a planet of nearly 10 billion people, Bloomberg says.

In Nature this week: new RNA editing approach called LEAPER, draft assembly of Musa balbisiana banana genome, and more.